Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Richard S. P. Hsi"'
Autor:
Wayne T. Stolle, Richard S. P. Hsi, Susanne R. Haadsma-Svensson, Chiu-Hong Lin, Mark J. Ackland, John A. Easter
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 39:891-900
The title compound is a potent and selective 5-HT 1A receptor agonist with clinical potentials for treating anxiety and depression. It has been labeled with stable and radioactive isotopes to support ADME studies in animals and human subjects. Its ca
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 38:1087-1098
(R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (1) is a dopamine agonist which shows selectivity for the D2 receptor subtype, and is of interest as a potential drug for the treatment of Parkinson's disease. An asymmetric epoxi
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 34:1175-1186
In the search for a radioactive form of the peptidomimetic renin inhibitor, ditekiren, with a metabolically suitable radiolabel for conducting drug disposition studies, we prepared [3H]ditekiren with tritium labels in the N-methyl-histidine moiety an
Autor:
Wayne T. Stolle, John R. Palmer, Richard S. P. Hsi, E. H. Chew, J. A. Easter, James P. McGrath
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 34:1187-1199
Tirilazad mesylate, 21-[4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16α-methyl-pregna-1,4,9(11)-triene-3,20-dione monomethanesulfonate, is a potent lipid peroxidation inhibitor capable of suppressing progression of tissue damage caused by
Autor:
Salvatore Charles Perricone, Jackson B. Hester, Wayne T. Stolle, Richard S. P. Hsi, Lindsay S. Stelzer
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 34:929-942
Ibutilide fumarate, racemic N-[4-[4-(ethyl-n-heptylamino)-1-hydroxybutyl]phenyl]methanesulfonamide hemifumarate, and artilide, the R-(+)-enantiomer of N-[4-[4-(di-n-butylalmino)-1-hydroxybutyl]-phenyl]methanesulfonamide hemifumerate, are under clinic
Autor:
Gordon L. Bundy, J. A. Easter, Y. Philopoulos, Richard S. P. Hsi, A. J. Wickrema Sinha, L. S. Banitt
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 33:827-838
This report describes an efficient stereoselective synthesis of [11β-3H]prostaglandin E1 ([11β-3H]PGE1). The key multiply protected 11-keto intermediate was prepared in only three steps from PGE1. Reduction of the ketone function at C-11 with sodiu
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 28:555-580
Methylprednisolone suleptanate was initially labeled with tritium in the A-ring of the steroid portion of the molecule, and with carbon-14 at both carboxylic carbons of the suberic acid portion of the side chain. However these labels proved to lack t
Autor:
Wayne T. Stolle, Richard S. P. Hsi
Publikováno v:
Journal of Labelled Compounds and Radiopharmaceuticals. 38:1147-1149
Palladium-on-charcoal catalyzed reduction of N-methyl-3-(3-bromo)phenyl-3-(4-trifluoromethyl)phenoxypropylamine (1) with tritium gas produces a mixture of the debrominated product [ 3 H]fluoxetine (2) and N-methyl-3-[3- 3 H]phenylpropylamine(3), whic
Publikováno v:
Isotope Production and Applications in the 21st Century.
Autor:
Robert A. Lahti, Malcolm W. Moon, D.L. Evans, K.J. Carrigan, Lana M. Figur, Richard S. P. Hsi
Publikováno v:
European Journal of Pharmacology. 202:289-291
U-86170F, an imidazoguinolinone, is a potent dopamine D2 agonist, binding with high affinity to the dopamine D2 receptor. A Kd of 0.99 nM was determined in membranes from Chinese hamster ovarian (CHO) cells transfected with the D2 receptor and a Kd o